Thank you is all one can say
Editorial by Bruce Shriver, PhD
There is no reason to include age as an entry criterion for any clinical trial
CTOS Op Ed: Dr. Paul Meyers gives rationale as to why he makes the above statement.
CTOS OP ED: Questions, Comments and Counterpoints
Point & Counterpoint regarding the "Leiomyosarcoma of the Uterus: A Review" article that appeared in the last issue of ESUN.
Novel Approaches for the Molecular Targeting of Ewing's Sarcoma Family of Tumors
Drs. Schlottmann and Toretsky review promising targeted therapy approaches to treat ESFT.
Collaborative Practice: Partners in Caring
Denise Reinke discuss how nurses and physicians work together to deliver care to patients with sarcomas in this issue's From a Nurse's Perspective column.
Leiomyosarcoma Research Study Funded
This project represents the first attempt to classify leiomyosarcomas based on their miRNA profile, and to explore the contribution of miRNAs to the smooth-muscle oncogenic transformation process.
Two Distinguished Physicians Join ESUN's Medical Advisory and Editorial Board
We are pleased to announce that Luca Sangiorgi, MD, PhD and Dr. Ernest "Chappie" Conrad, MD, both internationally recognized for their contributions to the sarcoma community, have joined ESUN's Medical Advisory and Editorial Board.